Skip to main content
NewslettersWatchlist

Devonian Health Group Inc(GSD-X)
TSX Venture

Today's Change
Delayed Last Update

Devonian Health Group Inc

360, Rue des Entrepreneurs
Montmagny QC G5V 4T1 CAN
P: 514-248-7509
https://www.groupedevonian.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It is intended to develop prescription botanical drugs which could be from plant materials, algae, macroscopic fungi, and combinations thereof. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provide a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. The products of the group include botanical pharmaceuticals, Thykamine; and derma-cosmeceutical product, Purgenesis.

    Key Executives

    NameTitle
    Andre P. BouletChief Scientific Officer/Director
    Colette LaurinCFO/Controller
    Pierre J. MontanaroCEO/Director/President
    Daniel BouthillierVice President, Divisional
    John SampalisVice President, Divisional

    More from The Globe

    investor newsletter
    A look at how people are using the best all-around investing product. Plus, top stock picks from our new Readers’ Portfolio
    ETF or Exchange Traded Fund text on black block
    The close: Month-end repositioning spurs late-day stock rally
    Trader Anthony Confusione works on the floor of the New York Stock Exchange, Thursday, May 30.
    Why this money manager thinks investors should get off the sidelines but still be defensive
    Illustration of Chris Kerlow for The Mover. June 23/24, 2023. Illustration by Joel Kimmel
    globe advisor weekly newsletter
    Canadian investors are ‘underserved’ in alternative investments and private capital
    Investors want greater clarity from their advisors around what RI means and how it can fit their portfolios.
    Why rising interest in traditional fixed income is not affecting alternatives
    A man looks up as he leans a red ladder against a tall stack of coins that is topped with an interest rate symbol.
    Fund houses buy up ‘alts’ specialists to move beyond equities and bonds
    FILE PHOTO: Larry Fink, Chief Executive Officer of BlackRock, takes part in the Yahoo Finance All Markets Summit in New York, U.S., February 8, 2017. REUTERS/Lucas Jackson
    opinion
    Four reasons why wealthy investors should hold farmland in their portfolios
    Andrea Gruza
    Four ways to create more diversified and resilient portfolios
    One of a set. Graphic Arrow on abstract background.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.